Healthcare Industry News: bladder cancer
News Release - January 2, 2008
Barnev, Inc. Names John Quigley Vice President, MarketingIndustry Veteran to Take Reins of Continuous Labor Monitoring Provider's Global Marketing
ANDOVER, Mass.--(HSMN NewsFeed)--Barnev, Inc., providers of BirthTrack™, a continuous labor monitoring system, today announced the appointment of John Quigley as vice president, marketing.
“John has a proven track record of success in developing strategies, building high performance marketing organizations, and bringing products to market that change clinical practices,” said Ron Greene, CEO, Barnev, Inc. “John’s broad medical technology background and extensive experience working with high growth companies will be a tremendous addition to our team.”
Quigley has over 25 years of executive experience in the biotech, medical device, and critical care industries. Prior to joining Barnev, he was the vice president of marketing for Matritech, Inc., an emerging biotech firm in the field of early cancer detection. At Matritech, Quigley developed strategic plans to market new diagnostics for the detection of prostate and breast cancer and to expand the use of Matritech’s bladder cancer test into the OB/GYN and primary care physician segments.
Quigley has also held various senior-level sales and marketing positions with Argose Corporation, Bayer Corporation, Chiron Diagnostics, and Boehringer Mannheim.
About Barnev, Inc.
Barnev, Inc. manufactures and sells BirthTrack, a continuous labor monitoring technology that accurately and safely monitors in real time both cervical dilatation and fetal head descent in the birth canal during the labor process. BirthTrack is FDA cleared and CE approved, and has been introduced into U.S. and other global markets. For more information, please visit www.barnev.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.